#Canada #Toronto #Medical Imaging #Perimeter Medical #Cancer Technology

Overview of Perimeter Medical Imaging AI Presentation

Perimeter Medical Imaging AI, Inc. will be making a notable appearance at the upcoming Small Cap Growth Virtual Investor Conference, scheduled for October 16, 2025. With their focus on innovative solutions in medical technology, Perimeter has positioned itself as a key player in the realm of cancer surgery assistance. The presentation, delivered by CEO Adrian Mendes, promises to shed light on the company's current status, advancements, and future prospects.

Details of the Conference

The Small Cap Growth Virtual Investor Conference (VIC) aims to bring together a diverse range of small-cap investors, both retail and institutional, providing them with a platform to learn about emerging companies. Since its inception in 2010, the VIC has successfully introduced thousands of investors to over 2,000 publicly traded entities. It represents an incredible opportunity for companies like Perimeter to showcase their advancements in technology to an engaged audience.

About Perimeter Medical Imaging AI

Based in Toronto, Canada, and Dallas, Texas, Perimeter Medical Imaging AI is dedicated to revolutionizing cancer surgery with ultra-high-resolution, advanced imaging tools. These tools are designed specifically to address the urgent needs surrounding cancer treatment. Their FDA-cleared Perimeter S-Series Optical Coherence Tomography (OCT) system provides real-time, cross-sectional imaging of excised tissues at the cellular level, a significant technological advancement in the field.

The company is also in the process of developing the next generation of imaging technology with the Perimeter B-Series OCT, which incorporates ImgAssist AI technology. This investigational device has been assessed in clinical trials and has received substantial financial backing from the Cancer Prevention and Research Institute of Texas, amounting to approximately US$7.4 million. Although the B-Series is still under evaluation and not available for commercial sale in the U.S., it represents a vital step forward in cancer surgery assistance.

Importance of the Presentation

Mendes' presentation will not only highlight the company’s technological innovations but also emphasize its commitment to improving patient outcomes in cancer treatment. For investors, this presentation offers valuable insights into Perimeter's strategic direction and its potential impact on the healthcare landscape.

Conclusion

As the virtual conference approaches, stakeholders and interested parties should mark their calendars for October 16. The updates from Perimeter Medical Imaging AI promise to be imperative in understanding the company’s role in transforming cancer care. For more information on the company's initiatives, interested individuals can access presentations live through their official website. This opportunity for engagement with a dedicated investor audience will undoubtedly shine a light on Perimeter’s future endeavors and contributions to medical technology.